Morgan Stanley Biote Corp. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Biote Corp. stock. As of the latest transaction made, Morgan Stanley holds 139,633 shares of BTMD stock, worth $922,974. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,633
Previous 98,926
41.15%
Holding current value
$922,974
Previous $738,000
5.56%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BTMD
# of Institutions
83Shares Held
17.7MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$30.1 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$16.1 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$9.37 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$9.21 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $50.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...